Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Abstract Text:

    t y halimT Y Halim,k w songK W Song,m j barnettM J Barnett,d l forrestD L Forrest,d e hoggeD E Hogge,s h nantelS H Nantel,t j nevillT J Nevill,j d shepherdJ D Shepherd,c a smithC A Smith,h j sutherlandH J Sutherland,c l tozeC L Toze,j c lavoieJ C Lavoie,t y halimT Y Halim,k w songK W Song,m j barnettM J Barnett,d l forrestD L Forrest,d e hoggeD E Hogge,s h nantelS H Nantel,t j nevillT J Nevill,j d shepherdJ D Shepherd,c a smithC A Smith,h j sutherlandH J Sutherland,c l tozeC L Toze,j c lavoieJ C Lavoie,

    BACKGROUND: Curative intent chemotherapy for acute myelogenous leukemia (AML) leads to prolonged severe neutropenia, during which patients are highly susceptible to infection. Traditionally these high-risk patients were treated as inpatients. Our center recently implemented a selective ambulatory management policy for AML patients undergoing chemotherapy. MATERIALS AND METHODS: A retrospective analysis was conducted to assess the occurrence of septicemia in AML patients treated over a 5 years period with curative intent chemotherapy. This review encompasses a change in policy from primarily inpatient care to selective outpatient management coupled with prophylactic antibiotic therapy. RESULTS: A total of 294 patients, receiving 623 cycles of chemotherapy were identified. A significant decrease in septicemia was observed from the inpatient to outpatient cohort (22% to 13% P < 0.05), which correlated with the shift towards outpatient treatment of consolidation cycles. A shift from Gram-negative to Gram-positive organisms as the cause of septicemia was also detected in the outpatient cohort, likely due to the introduction of ciprofloxacin prophylaxis. No significant emerging resistance and no septicemia-related mortality were noted in the outpatient cohort. CONCLUSION: The observed decrease in the incidence of septicemia in the ambulatory cohort adds supportive evidence to the feasibility of selective outpatient management of AML patients with respect to infectious complications.

    Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Publishing Authors By Initials

    ty halimTY Halim,kw songKW Song,mj barnettMJ Barnett,dl forrestDL Forrest,de hoggeDE Hogge,sh nantelSH Nantel,tj nevillTJ Nevill,jd shepherdJD Shepherd,ca smithCA Smith,hj sutherlandHJ Sutherland,cl tozeCL Toze,jc lavoieJC Lavoie,ty halimTY Halim,kw songKW Song,mj barnettMJ Barnett,dl forrestDL Forrest,de hoggeDE Hogge,sh nantelSH Nantel,tj nevillTJ Nevill,jd shepherdJD Shepherd,ca smithCA Smith,hj sutherlandHJ Sutherland,cl tozeCL Toze,jc lavoieJC Lavoie,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Annals of oncology : official journal of the Europ

    VOLUME: 18

    Page Numbers: 1246-52

    Journal Abbreviation: Ann. Oncol.

    ISSN: 0923-7534

    DAY: 17

    MONTH: 04

    YEAR: 2007

    Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9007735

    Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.

    AFFILIATION: Department of Immunology and Microbiology, University of British Columbia, Vancouver, Canada.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News